Air-handling capabilities of blood cardioplegia delivery systems in a simulated pediatric model

David Palanzo, Yulong Guan, Caihong Wan, Larry Baer, Allen Kunselman, Feng Qiu, Akif Undar

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Blood cardioplegia delivery systems are employed in most pediatric open heart cases to arrest the heart and keep it preserved during aortic cross-clamping. They are also used as part of a modified ultrafiltration system at the end of cardiopulmonary bypass. We evaluated and compared the air-handling capabilities of different types of blood cardioplegia delivery devices. A simple circuit incorporating a cardiotomy reservoir, a roller pump, a cardioplegia test system, and two emboli detection and classification sensors were used to investigate the air-handling capabilities of the following cardioplegia delivery systems: GISH Vision, Maquet Plegiox, Medtronic Trillium MYOtherm XP, Sorin Group BCD Vanguard, Sorin Group CSC14, and Terumo Sarns Conducer and Bubble Trap. The 0.25-in. circuit was primed with 400 mL of Lactated Ringer's. Outdated packed red blood cells were added to obtain a hematocrit of 24-28%. System pressure was maintained at 50 mm Hg. Air (0.1, 0.3, 0.5 mL) was injected at a speed of 0.1 mL/s into the circuit just after the pump head. Gaseous microemboli (GME) were measured prior to the cardioplegia system and after the device to evaluate the air-handling characteristics. The tests were run at 100, 200, and 400 mL/min blood flow for both 4 and 37°C. There were no significant differences among the groups when comparing precardioplegia delivery system GME, thus demonstrating that all devices received the same amount of injected air. When comparing the groups for postcardioplegia delivery system GME, significant differences were noted especially at the 400 mL/min blood flow rate. These results suggest that for the devices compared in this study, the Maquet Plegiox and the Medtronic Trillium MYOtherm XP eliminated GME the best.

Original languageEnglish (US)
Pages (from-to)950-954
Number of pages5
JournalArtificial organs
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2010

Fingerprint

Induced Heart Arrest
Pediatrics
Blood
Air
Trillium
Equipment and Supplies
Networks (circuits)
Pumps
Ultrafiltration
Heart Arrest
Embolism
Cardiopulmonary Bypass
Hematocrit
Constriction
Erythrocytes
Head
Cells
Flow rate
Pressure
Sensors

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Palanzo, David ; Guan, Yulong ; Wan, Caihong ; Baer, Larry ; Kunselman, Allen ; Qiu, Feng ; Undar, Akif. / Air-handling capabilities of blood cardioplegia delivery systems in a simulated pediatric model. In: Artificial organs. 2010 ; Vol. 34, No. 11. pp. 950-954.
@article{ffe1689a64c24fb183af9d8e03ef8b1f,
title = "Air-handling capabilities of blood cardioplegia delivery systems in a simulated pediatric model",
abstract = "Blood cardioplegia delivery systems are employed in most pediatric open heart cases to arrest the heart and keep it preserved during aortic cross-clamping. They are also used as part of a modified ultrafiltration system at the end of cardiopulmonary bypass. We evaluated and compared the air-handling capabilities of different types of blood cardioplegia delivery devices. A simple circuit incorporating a cardiotomy reservoir, a roller pump, a cardioplegia test system, and two emboli detection and classification sensors were used to investigate the air-handling capabilities of the following cardioplegia delivery systems: GISH Vision, Maquet Plegiox, Medtronic Trillium MYOtherm XP, Sorin Group BCD Vanguard, Sorin Group CSC14, and Terumo Sarns Conducer and Bubble Trap. The 0.25-in. circuit was primed with 400 mL of Lactated Ringer's. Outdated packed red blood cells were added to obtain a hematocrit of 24-28{\%}. System pressure was maintained at 50 mm Hg. Air (0.1, 0.3, 0.5 mL) was injected at a speed of 0.1 mL/s into the circuit just after the pump head. Gaseous microemboli (GME) were measured prior to the cardioplegia system and after the device to evaluate the air-handling characteristics. The tests were run at 100, 200, and 400 mL/min blood flow for both 4 and 37°C. There were no significant differences among the groups when comparing precardioplegia delivery system GME, thus demonstrating that all devices received the same amount of injected air. When comparing the groups for postcardioplegia delivery system GME, significant differences were noted especially at the 400 mL/min blood flow rate. These results suggest that for the devices compared in this study, the Maquet Plegiox and the Medtronic Trillium MYOtherm XP eliminated GME the best.",
author = "David Palanzo and Yulong Guan and Caihong Wan and Larry Baer and Allen Kunselman and Feng Qiu and Akif Undar",
year = "2010",
month = "11",
day = "1",
doi = "10.1111/j.1525-1594.2010.01118.x",
language = "English (US)",
volume = "34",
pages = "950--954",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "11",

}

Air-handling capabilities of blood cardioplegia delivery systems in a simulated pediatric model. / Palanzo, David; Guan, Yulong; Wan, Caihong; Baer, Larry; Kunselman, Allen; Qiu, Feng; Undar, Akif.

In: Artificial organs, Vol. 34, No. 11, 01.11.2010, p. 950-954.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Air-handling capabilities of blood cardioplegia delivery systems in a simulated pediatric model

AU - Palanzo, David

AU - Guan, Yulong

AU - Wan, Caihong

AU - Baer, Larry

AU - Kunselman, Allen

AU - Qiu, Feng

AU - Undar, Akif

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Blood cardioplegia delivery systems are employed in most pediatric open heart cases to arrest the heart and keep it preserved during aortic cross-clamping. They are also used as part of a modified ultrafiltration system at the end of cardiopulmonary bypass. We evaluated and compared the air-handling capabilities of different types of blood cardioplegia delivery devices. A simple circuit incorporating a cardiotomy reservoir, a roller pump, a cardioplegia test system, and two emboli detection and classification sensors were used to investigate the air-handling capabilities of the following cardioplegia delivery systems: GISH Vision, Maquet Plegiox, Medtronic Trillium MYOtherm XP, Sorin Group BCD Vanguard, Sorin Group CSC14, and Terumo Sarns Conducer and Bubble Trap. The 0.25-in. circuit was primed with 400 mL of Lactated Ringer's. Outdated packed red blood cells were added to obtain a hematocrit of 24-28%. System pressure was maintained at 50 mm Hg. Air (0.1, 0.3, 0.5 mL) was injected at a speed of 0.1 mL/s into the circuit just after the pump head. Gaseous microemboli (GME) were measured prior to the cardioplegia system and after the device to evaluate the air-handling characteristics. The tests were run at 100, 200, and 400 mL/min blood flow for both 4 and 37°C. There were no significant differences among the groups when comparing precardioplegia delivery system GME, thus demonstrating that all devices received the same amount of injected air. When comparing the groups for postcardioplegia delivery system GME, significant differences were noted especially at the 400 mL/min blood flow rate. These results suggest that for the devices compared in this study, the Maquet Plegiox and the Medtronic Trillium MYOtherm XP eliminated GME the best.

AB - Blood cardioplegia delivery systems are employed in most pediatric open heart cases to arrest the heart and keep it preserved during aortic cross-clamping. They are also used as part of a modified ultrafiltration system at the end of cardiopulmonary bypass. We evaluated and compared the air-handling capabilities of different types of blood cardioplegia delivery devices. A simple circuit incorporating a cardiotomy reservoir, a roller pump, a cardioplegia test system, and two emboli detection and classification sensors were used to investigate the air-handling capabilities of the following cardioplegia delivery systems: GISH Vision, Maquet Plegiox, Medtronic Trillium MYOtherm XP, Sorin Group BCD Vanguard, Sorin Group CSC14, and Terumo Sarns Conducer and Bubble Trap. The 0.25-in. circuit was primed with 400 mL of Lactated Ringer's. Outdated packed red blood cells were added to obtain a hematocrit of 24-28%. System pressure was maintained at 50 mm Hg. Air (0.1, 0.3, 0.5 mL) was injected at a speed of 0.1 mL/s into the circuit just after the pump head. Gaseous microemboli (GME) were measured prior to the cardioplegia system and after the device to evaluate the air-handling characteristics. The tests were run at 100, 200, and 400 mL/min blood flow for both 4 and 37°C. There were no significant differences among the groups when comparing precardioplegia delivery system GME, thus demonstrating that all devices received the same amount of injected air. When comparing the groups for postcardioplegia delivery system GME, significant differences were noted especially at the 400 mL/min blood flow rate. These results suggest that for the devices compared in this study, the Maquet Plegiox and the Medtronic Trillium MYOtherm XP eliminated GME the best.

UR - http://www.scopus.com/inward/record.url?scp=78649530767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649530767&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2010.01118.x

DO - 10.1111/j.1525-1594.2010.01118.x

M3 - Article

VL - 34

SP - 950

EP - 954

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 11

ER -